Patient compliance in the treatment of arterial hypertension

Blood Pressure

Volumn 11, Issue 4, 2002, Pages 253-254

  Mallion, J M ^a   Schmitt, D ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG URINE LEVEL; HEALTH CARE COST; HEALTH PRACTITIONER; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SIDE EFFECT; SOCIAL CLASS; ARTERY; DISEASE MANAGEMENT; PATHOLOGY; STATISTICS;

ARTERIES; DISEASE MANAGEMENT; HUMANS; HYPERTENSION; PATIENT COMPLIANCE;

EID: 0036380258     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050213755     Document Type: Article

References (15)

1. Alderman Mh, Budner N, Cohen H, Lamport B, Ooi W.L. Prevalence of drug resistant hypertension. Hypertension 1988; 11 (suppl 11): 1171-1175.
2. Bailey BL, Carnery SL, Gillies AH, McColm LM, Smith AJ, Taylor M. Hypertension treatment compliance: what do patients want to know about their medications? Prog Cardiovacs Nurs 1997; 12(4): 23-8.
3. Bittar N. Maintaning long-term control of blood pressure: the role of improved compliance. Clin Cardiol 1995; 18: III12-III16.
4. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 1991; 48(9): 1978-88.
5. Edmonds D, Foerster E, Groth H, Greminger P, Siegenthaler W, Vetter W. Does self-measurement of blood pressure improve patient compliance in hypertension. J Hypertens 1985; 3(suppl 1): S31-S34.
6. Eisen SA, Woodward RS, Miller D, Spitznagel E, Windham CA. The effect of medication compliance on the control of hypertension. J Gen Intern Med 1987; 2(5): 298-305.
7. Fallab-Stübi CL, Zellweger JP, Sauty A, Uldry C, Iorillo D, Burnier M. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. Int J Tuberc Lung Dis 1998; 2(7); 525-30.
8. Gallup G Jr, Cotugno HE. Preferences and practices of Americans and their physicians in antihypertensive therapy. Am J Med 1986; 81:(suppl 6c): 20-24. Garfield FN, Caro JJ. Compliance and hypertension. Current Hypertension Reports 1999; 1: 502-6.
9. Garfield FN, Caro JJ. Compliance and hypertension. Current Hypertension Reports 1999; 1: 502-6.
10. Guerrero D, Rudd P, Bryant-Kosling C, Middleton BF. Antihypertensive Medication-Taking. Investigation of a simple regimen. Am J Hypertens 1993; 6: 586-92.
11. Heurtin-Roberts S, Reisin E. The relation of culturally influenced lay models of hypertension to compliance with treatment. Am J Hypertens 1992; 5(11): 787-92.
12. Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wrigth JT. Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney disease and hypertension (AASK) pilot study. Am J Hypertens 1996; 9(8): 719-25.
13. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and co-morbidity on antihypertensive therapy compliance. Results from a population-based study in the elderly. Am J Hypertens 1997; 10: 697-704.
14. Morisky DE, Levine DM, Green LW, Shapiro S, Russell P, Smith CR. Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health 1983; 73(2); 153-62.
15. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. NIH Publication Nov. 1997; N°98-4080: 69p.